Angiotensin-converting enzyme 2 activation suppresses pulmonary vascular remodeling by inducing apoptosis through the Hippo signaling pathway in rats with pulmonary arterial hypertension
Objective: To investigate the effects of angiotensin-converting enzyme 2 (ACE2) activation on pulmonary arterial cell apoptosis during pulmonary vascular remodeling associated with pulmonary arterial hypertension (PAH) and to elucidate potential mechanisms related to Hippo signaling. Methods: PAH mo...
Main Authors: | Daole Yan, Gang Li, Yaozhong Zhang, Yinglong Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-08-01
|
Series: | Clinical and Experimental Hypertension |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10641963.2019.1583247 |
Similar Items
-
Hepatoma‐derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survival
by: Jun Yang, et al.
Published: (2022-01-01) -
HIF-1α mediates hypertension and vascular remodeling in sleep apnea via hippo–YAP pathway activation
by: Shoude Zhang, et al.
Published: (2024-12-01) -
A ROLE OF ANGIOTENSIN-CONVERTING ENZYME IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE SUMMARY
by: N. D. Elshin, et al.
Published: (2017-09-01) -
TGF‐β/Smads signaling pathway, Hippo‐YAP/TAZ signaling pathway, and VEGF: Their mechanisms and roles in vascular remodeling related diseases
by: Hui Liu, et al.
Published: (2023-11-01) -
Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
by: Mario Boehm, et al.
Published: (2018-03-01)